Institution
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a Phase 2 interventional trial with planned enrollment of 220 participants studying drug combinations for metastatic breast cancer; results are not reported in this registry record.
Phase 2 interventional trial still recruiting with no results posted; designed to compare toxicity and disease-free survival in HER2-positive breast cancer but outcome data not yet available.
This is a Phase 1 pilot feasibility trial with no results posted; it measures toxicity and treatment completion in older patients but carries no outcome data to assess efficacy or comparative benefit.